Monterosa

Monterosa company information, Employees & Contact Information

Explore related pages

Related company profiles:

At Monterosa we love combining gaming with sports and broadcast to generate new experiences and business models. The world’s biggest sport, media and consumer brands are adopting Monterosa / Interaction Cloud™ to consolidate interactive engagement under one roof, generating measurable impact via first-party data, sign-up, sales and audience sentiment. They include ITV, EA SPORTS, Paramount, Liverpool Football Club and Formula E.

Company Details

Employees
143
Address
Mann Island, Liverpool,england L3 1bp,united Kingdom
Phone
+44 20 7269 0555
Email
in****@****a.co.uk
Industry
Software Development
NAICS
Software Publishers
HQ
Liverpool, England
Looking for a particular Monterosa employee's phone or email?

Monterosa Questions

News

Monterosa Ski (Gressoney / Alagna, Italy): April 4, 2025 - firsttracksonline.com

Monterosa Ski (Gressoney / Alagna, Italy): April 4, 2025 firsttracksonline.com

Novartis dives deeper into protein degraders with second Monte Rosa deal - BioPharma Dive

Novartis dives deeper into protein degraders with second Monte Rosa deal BioPharma Dive

Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases - GlobeNewswire

Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases GlobeNewswire

Pictet seeks up to $1.25bn for latest co-investment fund - Private Equity International | PEI

Pictet seeks up to $1.25bn for latest co-investment fund Private Equity International | PEI

Novartis assembles 2nd molecular glue deal with Monte Rosa, this one worth up to $5.7B - Fierce Biotech

Novartis assembles 2nd molecular glue deal with Monte Rosa, this one worth up to $5.7B Fierce Biotech

Novartis and Monte Rosa Therapeutics Announce $5.7 Billion Licensing Agreement Deal for Protein Degraders - Pharmaceutical Executive

Novartis and Monte Rosa Therapeutics Announce $5.7 Billion Licensing Agreement Deal for Protein Degraders Pharmaceutical Executive

Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B - BioSpace

Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B BioSpace

Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - Reuters

Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics Reuters

Monte Rosa surges premarket on Novartis collaboration deal - Investing.com

Monte Rosa surges premarket on Novartis collaboration deal Investing.com

Monte Rosa Therapeutics Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Monte Rosa Therapeutics Announces Second Quarter 2025 Financial Results and Business Updates GlobeNewswire

Novartis returns to Monte Rosa for second time in a year with $5.7bn deal - Pharmaceutical Technology

Novartis returns to Monte Rosa for second time in a year with $5.7bn deal Pharmaceutical Technology

Monte Rosa Therapeutics Inc Stock Price Today | NASDAQ: GLUE Live - Investing.com

Monte Rosa Therapeutics Inc Stock Price Today | NASDAQ: GLUE Live Investing.com

Monte Rosa doses first subjects in trial of MRT-8102 for inflammatory conditions - Clinical Trials Arena

Monte Rosa doses first subjects in trial of MRT-8102 for inflammatory conditions Clinical Trials Arena

Pictet closes Monte Rosa Fund VI and Monte Rosa Co-Investment V, flagship private equity funds - RankiaPro

Pictet closes Monte Rosa Fund VI and Monte Rosa Co-Investment V, flagship private equity funds RankiaPro

Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs - Reuters

Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs Reuters

Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs - GlobeNewswire

Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs GlobeNewswire

Monterosa Ski (Gressoney / Alagna / Champoluc, Italy ): February 1, 2023 | Liftlines Skiing and Snowboarding Forums - firsttracksonline.com

Monterosa Ski (Gressoney / Alagna / Champoluc, Italy ): February 1, 2023 | Liftlines Skiing and Snowboarding Forums firsttracksonline.com

Monte Rosa Therapeutics Announces First Subjects Dosed in Phase 1 Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases - GlobeNewswire

Monte Rosa Therapeutics Announces First Subjects Dosed in Phase 1 Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases GlobeNewswire

Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders - GlobeNewswire

Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders GlobeNewswire

Richard Scudamore Joins Monterosa Board - GlobeNewswire

Richard Scudamore Joins Monterosa Board GlobeNewswire

Monte Rosa joins with Novartis in ‘molecular glue’ drug deal - BioPharma Dive

Monte Rosa joins with Novartis in ‘molecular glue’ drug deal BioPharma Dive

Monte Rosa Therapeutics Announces Global License Agreement - GlobeNewswire

Monte Rosa Therapeutics Announces Global License Agreement GlobeNewswire

Roche pays $50M upfront to Monte Rosa in molecular glue deal fit for a QuEEN - Fierce Biotech

Roche pays $50M upfront to Monte Rosa in molecular glue deal fit for a QuEEN Fierce Biotech

Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - Yahoo! Finance Canada

Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics Yahoo! Finance Canada

Novartis Signs Global License Agreement with Monte Rosa Therapeutics Worth up to $2.1 Billion to Advance MGD-based Therapeutics - BioPharm International

Novartis Signs Global License Agreement with Monte Rosa Therapeutics Worth up to $2.1 Billion to Advance MGD-based Therapeutics BioPharm International

Monte Rosa, Novartis have one in VAV1, sign $2.1B pact - BioWorld MedTech

Monte Rosa, Novartis have one in VAV1, sign $2.1B pact BioWorld MedTech

Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases - GlobeNewswire

Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases GlobeNewswire

Lagos seals Monterosa Construction site after Crane crash kills operator - PM News Nigeria

Lagos seals Monterosa Construction site after Crane crash kills operator PM News Nigeria

Monte Rosa Announces Publication in Science of Key Insights - GlobeNewswire

Monte Rosa Announces Publication in Science of Key Insights GlobeNewswire

Novartis, Monte Rosa Ink Up To $5.7B 'Molecular Glue' Deal - Law360

Novartis, Monte Rosa Ink Up To $5.7B 'Molecular Glue' Deal Law360

Monte Rosa aims to be the protein degradation champion with $150M Novartis deal for autoimmune molecular glue - Fierce Biotech

Monte Rosa aims to be the protein degradation champion with $150M Novartis deal for autoimmune molecular glue Fierce Biotech

Novartis, Monte Rosa Launch Up-to-$2.1B Molecular Glue Collaboration - Genetic Engineering and Biotechnology News

Novartis, Monte Rosa Launch Up-to-$2.1B Molecular Glue Collaboration Genetic Engineering and Biotechnology News

Monte Rosa Therapeutics And The Promise Of Molecular Glue Degraders - Seeking Alpha

Monte Rosa Therapeutics And The Promise Of Molecular Glue Degraders Seeking Alpha

$5.7 Billion Biotech Deal: Monte Rosa Teams with Novartis on Revolutionary Protein Degrader Platform - Stock Titan

$5.7 Billion Biotech Deal: Monte Rosa Teams with Novartis on Revolutionary Protein Degrader Platform Stock Titan

Monterosa Looks to the Future with Eye on the Past - Olive Oil Times

Monterosa Looks to the Future with Eye on the Past Olive Oil Times

UKC Gear - REVIEW: Julbo Sunglasses: Monterosa 2, Montebianco 2 and Shield M - UKClimbing

UKC Gear - REVIEW: Julbo Sunglasses: Monterosa 2, Montebianco 2 and Shield M UKClimbing

ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds - The Institute of Cancer Research

ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds The Institute of Cancer Research

Monterosa | Ski resort Review - Snow Magazine

Monterosa | Ski resort Review Snow Magazine

Monte Rosa Therapeutics Provides Development Progress Update for Ongoing MRT-2359 Phase 1/2 Study in Patients with MYC-driven Solid Tumors - GlobeNewswire

Monte Rosa Therapeutics Provides Development Progress Update for Ongoing MRT-2359 Phase 1/2 Study in Patients with MYC-driven Solid Tumors GlobeNewswire

Pictet adds new vintage to Monte Rosa private equity strategy - Citywire

Pictet adds new vintage to Monte Rosa private equity strategy Citywire

Semillas Fitó, S.A. and Mastronardi Produce Ltd Partner to Bring Monterosa Tomato to North America - AndNowUKnow

Semillas Fitó, S.A. and Mastronardi Produce Ltd Partner to Bring Monterosa Tomato to North America AndNowUKnow

Odlo Gets New Owner - ISPO.com

Odlo Gets New Owner ISPO.com

Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer - GlobeNewswire

Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer GlobeNewswire

Monterosa tomatoes distributed in Italy - Hortidaily

Monterosa tomatoes distributed in Italy Hortidaily

The World Food Innovation Awards awards the Monterosa tomato as the best natural and organic product - Hortidaily

The World Food Innovation Awards awards the Monterosa tomato as the best natural and organic product Hortidaily

Red Bull Snowthrill Monterosa 2006, the participants - Planetmountain.com

Red Bull Snowthrill Monterosa 2006, the participants Planetmountain.com

Aethos Monterosa: indigenous materials and Tesla charging - Lampoon Magazine

Aethos Monterosa: indigenous materials and Tesla charging Lampoon Magazine

Red Bull Snowthrill Monterosa 2006: date fixed for 13 March! - Planetmountain.com

Red Bull Snowthrill Monterosa 2006: date fixed for 13 March! Planetmountain.com

Julbo MonteRosa Sunglass – Sport Sunglasses: Reviews - Outside Magazine

Julbo MonteRosa Sunglass – Sport Sunglasses: Reviews Outside Magazine

The 10 greatest ski resorts in Italy - The Telegraph

The 10 greatest ski resorts in Italy The Telegraph

Oscar Sosa from Argentina wins the Red Bull Snowthrill Monterosa 2006 - Planetmountain.com

Oscar Sosa from Argentina wins the Red Bull Snowthrill Monterosa 2006 Planetmountain.com

Aosta: Into the Valley - Snow Magazine

Aosta: Into the Valley Snow Magazine

Summer holidays in the Alps: eight great ideas - The Guardian

Summer holidays in the Alps: eight great ideas The Guardian

Monterosa, a tomato ‘as before’ - eComercio Agrario

Monterosa, a tomato ‘as before’ eComercio Agrario

Gressoney-la-Trinite - Snow Forecast

Gressoney-la-Trinite Snow Forecast

Off piste skiing: Monterosa, Italy, is powder perfect for freeriders - The Telegraph

Off piste skiing: Monterosa, Italy, is powder perfect for freeriders The Telegraph

Sta Lucia develops Monte Rosa Estate - Philstar.com

Sta Lucia develops Monte Rosa Estate Philstar.com

Top Monterosa Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant